Your browser is no longer supported. Please, upgrade your browser.
Neogen Corporation
Index- P/E73.03 EPS (ttm)1.13 Insider Own0.20% Shs Outstand53.13M Perf Week-1.61%
Market Cap4.39B Forward P/E61.29 EPS next Y1.35 Insider Trans-55.96% Shs Float53.06M Perf Month-4.96%
Income60.30M PEG7.30 EPS next Q0.26 Inst Own93.90% Short Float2.91% Perf Quarter12.13%
Sales433.30M P/S10.13 EPS this Y-2.00% Inst Trans-2.62% Short Ratio7.38 Perf Half Y10.88%
Book/sh14.63 P/B5.66 EPS next Y12.03% ROA7.40% Target Price81.50 Perf Year21.66%
Cash/sh7.37 P/C11.23 EPS next 5Y10.00% ROE8.10% 52W Range48.91 - 89.32 Perf YTD4.34%
Dividend- P/FCF62.17 EPS past 5Y10.90% ROI7.50% 52W High-7.37% Beta0.45
Dividend %- Quick Ratio10.90 Sales past 5Y8.10% Gross Margin46.30% 52W Low69.17% ATR2.74
Employees1764 Current Ratio13.00 Sales Q/Q6.70% Oper. Margin16.50% RSI (14)46.15 Volatility3.39% 3.34%
OptionableYes Debt/Eq0.00 EPS Q/Q-3.40% Profit Margin13.90% Rel Volume0.63 Prev Close84.47
ShortableYes LT Debt/Eq0.00 EarningsDec 22 BMO Payout0.00% Avg Volume209.50K Price82.74
Recom2.50 SMA20-1.89% SMA50-0.42% SMA2008.74% Volume132,120 Change-2.05%
May-23-19Initiated Guggenheim Neutral
Dec-05-17Resumed ROTH Capital Neutral $82
Jul-14-17Initiated CL King Neutral
Jun-05-14Initiated William Blair Mkt Perform
Mar-31-11Upgrade Hilliard Lyons Underperform → Neutral
Sep-25-09Reiterated Roth Capital Buy $33 → $36
Jul-22-09Reiterated Roth Capital Buy $29 → $33
Mar-20-09Reiterated Roth Capital Buy $32 → $28
Jan-07-09Reiterated Roth Capital Buy $33 → $32
Sep-25-08Reiterated Roth Capital Buy $30 → $33
Jan-04-08Reiterated Roth Capital Buy $28 → $30
Sep-28-07Reiterated Roth Capital Buy $23.33 → $28
Jul-25-07Reiterated Roth Capital Buy $33 → $35
Jul-09-07Reiterated Roth Capital Buy $27 → $33
May-08-07Initiated Susquehanna Financial Positive
Feb-15-21 10:00AM  
Feb-09-21 05:40AM  
Feb-01-21 08:45AM  
Jan-21-21 11:30AM  
Jan-18-21 08:41AM  
Jan-14-21 12:12PM  
Jan-13-21 10:18AM  
Jan-12-21 09:52AM  
Jan-07-21 12:13PM  
Jan-06-21 01:30PM  
Jan-04-21 08:45AM  
Dec-23-20 08:42AM  
Dec-22-20 03:30PM  
Dec-21-20 04:27AM  
Dec-16-20 03:19PM  
Dec-14-20 11:46AM  
Dec-08-20 08:45AM  
Nov-20-20 10:14AM  
Nov-13-20 07:07AM  
Oct-28-20 08:45AM  
Oct-22-20 12:03PM  
Oct-15-20 11:30AM  
Oct-14-20 02:36PM  
Oct-08-20 09:55AM  
Oct-07-20 08:40AM  
Oct-06-20 12:45PM  
Oct-01-20 07:06PM  
Sep-23-20 09:30AM  
Sep-22-20 04:30PM  
Sep-16-20 08:45AM  
Sep-15-20 12:30PM  
Sep-03-20 08:45AM  
Sep-02-20 11:26AM  
Sep-01-20 09:05AM  
Aug-20-20 11:30AM  
Aug-17-20 09:12AM  
Aug-13-20 08:45AM  
Aug-03-20 08:45AM  
Jul-24-20 10:20AM  
Jul-22-20 10:43AM  
Jul-21-20 03:30PM  
Jul-16-20 08:45AM  
Jul-15-20 08:45AM  
Jul-01-20 01:08AM  
May-27-20 09:35AM  
May-19-20 10:33AM  
May-18-20 08:45AM  
May-06-20 09:00AM  
Apr-23-20 11:30AM  
Apr-21-20 08:54AM  
Apr-16-20 04:01PM  
Apr-10-20 05:30PM  
Apr-07-20 08:45AM  
Mar-31-20 08:45AM  
Mar-27-20 10:47AM  
Mar-25-20 09:46AM  
Mar-24-20 09:55AM  
Mar-17-20 12:30PM  
Mar-12-20 08:45AM  
Mar-03-20 07:51AM  
Mar-02-20 08:45AM  
Feb-17-20 11:11AM  
Feb-05-20 09:45AM  
Feb-03-20 08:45AM  
Jan-30-20 08:45AM  
Jan-22-20 11:30AM  
Jan-21-20 09:08PM  
Jan-20-20 09:28AM  
Jan-13-20 08:45AM  
Jan-09-20 08:45AM  
Jan-07-20 08:45AM  
Jan-06-20 08:45AM  
Dec-24-19 09:26AM  
Dec-23-19 11:05AM  
Dec-20-19 10:08AM  
Dec-19-19 08:45AM  
Dec-14-19 04:30PM  
Dec-13-19 09:08AM  
Dec-12-19 12:30PM  
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lilly Jason WarrenVice President, InternationalFeb 05Sale85.232,265193,05211,346Feb 08 02:31 PM
PAPESH BRUCEDirectorJan 13Option Exercise27.9830,000839,52066,261Jan 14 08:27 AM
PAPESH BRUCEDirectorJan 13Sale83.4030,0002,502,06336,261Jan 14 08:27 AM
Quinlan Steven J.Vice President & CFOJan 07Option Exercise40.469,333377,63722,803Jan 07 06:53 PM
ADENT JOHN EDWARDPresident & CEOJan 07Option Exercise51.2920,0001,025,85036,080Jan 08 09:24 AM
Quinlan Steven J.Vice President & CFOJan 07Sale84.499,333788,52613,470Jan 07 06:53 PM
Lilly Jason WarrenVice President, InternationalJan 06Option Exercise63.3312,600797,94024,632Jan 07 08:14 AM
Lilly Jason WarrenVice President, InternationalJan 06Sale82.9111,021913,71613,611Jan 07 08:14 AM
BOEHM WILLIAM TDirectorJan 05Option Exercise31.243,00093,72013,479Jan 06 04:19 PM
BOEHM WILLIAM TDirectorJan 05Sale80.723,000242,17110,479Jan 06 04:19 PM
Lilly Jason WarrenVice President, InternationalNov 16Option Exercise40.4616,001647,44020,932Nov 18 06:13 PM
Lilly Jason WarrenVice President, InternationalNov 16Sale73.2314,3781,052,91412,032Nov 18 06:13 PM
Quinlan Steven J.Vice President & CFONov 03Option Exercise35.346,666235,57620,136Nov 04 02:40 PM
Quinlan Steven J.Vice President & CFONov 03Sale70.546,666470,24013,470Nov 04 02:40 PM
Quinlan Steven J.Vice President & CFONov 02Option Exercise35.3480028,27214,270Nov 04 02:40 PM
Quinlan Steven J.Vice President & CFONov 02Sale70.5580056,43713,470Nov 04 02:40 PM
Lilly Jason WarrenVice PresidentOct 21Option Exercise35.346,666235,57617,075Oct 22 08:41 AM
Lilly Jason WarrenVice PresidentOct 21Sale70.626,666470,77010,409Oct 22 08:41 AM
HERBERT JAMES LDirectorOct 14Option Exercise35.3425,333895,26867,284Oct 16 04:18 PM
HERBERT JAMES LDirectorOct 14Sale70.9125,3331,796,33341,951Oct 16 04:18 PM
PAPESH G BRUCEDirectorOct 01Option Exercise16.824,00067,26036,261Oct 02 08:05 AM
HERBERT JAMES LDirectorSep 30Option Exercise40.4625,3331,025,03767,284Oct 02 08:00 AM
HERBERT JAMES LDirectorSep 30Sale78.6125,3331,991,36141,951Oct 02 08:00 AM
Lilly Jason WarrenVice PresidentAug 05Option Exercise62.705,681356,19916,090Aug 07 10:40 AM
Lilly Jason WarrenVice PresidentAug 05Sale80.085,681454,93210,409Aug 07 10:40 AM
Lilly Jason WarrenVice PresidentMay 05Sale64.0088556,64010,409May 07 05:24 PM
HERBERT JAMES LDirectorApr 21Sale66.1319,3681,280,835604Apr 23 06:46 PM
HERBERT JAMES LDirectorApr 03Sale63.1620,0001,263,20019,972Apr 07 02:20 PM
Tobin James PDirectorMar 26Buy60.6273444,4955,500Mar 27 05:58 PM
ADENT JOHN EDWARDPresident & CEOMar 25Buy58.241,750101,92016,080Mar 27 06:12 PM